Sevelamer Hydrochloride Tablet, Film Coated
Product Images NDC 0904-7209

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 0904-7209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

800mg Carton Label (0500034d 458c 42c5 918d 9acd22f0c28b 00)

This is a description for Sevelamer Hydrochloride tablets in a unit dose package. Each film-coated tablet contains 800 mg of sevelamer hydrochloride. The usual dosage instructions can be found in the product insert along with prescribing information, precautions, and warnings. It is recommended to store the tablets at 20-25°C and protect them from moisture. Dispense in a tight container and keep out of the reach of children. The package is for institutional use only and should be kept in its original pharmacy container. The drug product is from Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure-2 (Figure 2)

This description is not available.*

FDA Label Image

Figure-3 (Figure 3)

This is a report detailing the change in phosphorus levels from baseline during a study week for the treatment group receiving Sevelamer Hydrochloride. The measurements show values of 14, 18, 26, 30, 34, 38, and 42, indicating a gradual increase over time. This information can be useful for monitoring the effectiveness of the treatment in managing phosphorus levels.*

FDA Label Image

Glenmark-logo (Glenmark Logo)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.